UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Why Do Active Funds Underperform Benchmark? This overview breaks down fees, manager skill, and market efficiency to explain gaps in performance and how to navigate them.
22,441 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Goldman Sachs flags four tech, media, and telecom bets on its Conviction List, each carrying 40% to 100% upside to ta...
NVIDIA signals a major pivot away from China as export controls tighten and domestic AI chip ambitions surge, a move ...
February brought a notable rotation in markets. Developed markets ex-US, gold, and REITs stood out as some of the top...
As AI and cloud data reshape markets, two red-hot growth stocks 2026 could shine for bold investors. This guide break...
NVIDIA has built a powerful moat around AI hardware and software. This deep dive explains a compelling growth catalys...
Ready to build a durable, long-term growth portfolio? This piece highlights two compelling picks and concrete steps t...
Long-term compound growth in tech requires durable moats and disciplined capital allocation. Here are two powerhouse ...
A discount retailer is stacking double-digit comps on top of double-digit comps. This article breaks down what that m...
AI hype meets real-world finance. This article explains why I remain cautious on CoreWeave stock, with clear risks, n...
A massive ground-level image map built by pokémon players is now training robots that deliver meals and packages acro...
A data center hardware maker saw a dramatic stock drop this week amid regulatory and supply chain concerns. This guid...